跳至主要内容
临床试验/NL-OMON50743
NL-OMON50743已完成不适用

The oral cavity as a source of febrile neutropenia, an observational study in cancer patients treated with myelosuppressive chemotherapy - ORA-FEBRIS

Academisch Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosed with a solid cancer, lymphoma or multiple myeloma
  • - Planned treatment with myelosuppressive chemotherapy with FN risk of 10%-20%
  • (with or without targeted therapies or hormonal therapy)
  • - Willing and able to give written Informed consent
  • - Age 18 or older
  • - Presence of (partial) natural dentition and/or dental implants

排除标准

  • - Unable to give written informed consent
  • - Age under 18 years
  • - Prior irradiation to the head and neck
  • - Edentulous patients

研究者

相似试验